Nuwellis Inc (NUWE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nuwellis Inc (NUWE) has a cash flow conversion efficiency ratio of -0.804x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.15 Million) by net assets ($3.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Nuwellis Inc's balance sheet to measure how much of total assets are equity-financed.
Nuwellis Inc - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Nuwellis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Nuwellis Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Nuwellis Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nuwellis Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CCSC Technology International Holdings Limited Ordinary Shares
NASDAQ:CCTG
|
-0.041x |
|
Sure-Tech Investments LP
TA:STEC
|
-0.038x |
|
Accsys Technologies PLC
LSE:AXS
|
0.068x |
|
Uscom Ltd
AU:UCM
|
-7.065x |
|
Avrupa Minerals Ltd
V:AVU
|
-0.168x |
|
Blackrock Energy and Resources Income Trust PLC
LSE:BERI
|
0.014x |
|
Resource Base Ltd
AU:RBX
|
-0.169x |
|
UNITED OIL+GAS PLC LS-01
F:1UO
|
N/A |
Annual Cash Flow Conversion Efficiency for Nuwellis Inc (2003–2024)
The table below shows the annual cash flow conversion efficiency of Nuwellis Inc from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see Nuwellis Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $6.53 Million | $-9.59 Million | -1.469x | +73.71% |
| 2023-12-31 | $3.21 Million | $-17.94 Million | -5.586x | -355.66% |
| 2022-12-31 | $12.36 Million | $-15.15 Million | -1.226x | -78.27% |
| 2021-12-31 | $25.95 Million | $-17.84 Million | -0.688x | +32.29% |
| 2020-12-31 | $16.32 Million | $-16.57 Million | -1.016x | +87.65% |
| 2019-12-31 | $1.99 Million | $-16.37 Million | -8.225x | -235.31% |
| 2018-12-31 | $5.94 Million | $-14.56 Million | -2.453x | -234.14% |
| 2017-12-31 | $16.24 Million | $-11.92 Million | -0.734x | +92.08% |
| 2016-12-31 | $1.76 Million | $-16.29 Million | -9.273x | -390.92% |
| 2015-12-31 | $12.17 Million | $-22.99 Million | -1.889x | -143.69% |
| 2014-12-31 | $29.21 Million | $-22.64 Million | -0.775x | -130.92% |
| 2013-12-31 | $51.73 Million | $-17.36 Million | -0.336x | +66.78% |
| 2012-12-31 | $12.95 Million | $-13.08 Million | -1.010x | +64.52% |
| 2011-12-31 | $4.60 Million | $-13.09 Million | -2.848x | -85.26% |
| 2010-12-31 | $4.02 Million | $-6.18 Million | -1.537x | 0.00% |
| 2009-12-31 | $4.02 Million | $-6.18 Million | -1.537x | +59.74% |
| 2008-12-31 | $1.64 Million | $-6.25 Million | -3.819x | -314.53% |
| 2007-12-31 | $9.51 Million | $-8.76 Million | -0.921x | +25.15% |
| 2006-12-31 | $6.89 Million | $-8.48 Million | -1.231x | -14.82% |
| 2005-12-31 | $4.38 Million | $-4.70 Million | -1.072x | -61.61% |
| 2004-12-31 | $7.30 Million | $-4.84 Million | -0.663x | +92.54% |
| 2003-12-31 | $139.47K | $-1.24 Million | -8.886x | -- |
About Nuwellis Inc
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The compan… Read more